These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 8843287)

  • 21. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.
    Hoban DJ
    J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and mechanism of resistance against macrolides and lincosamides in Streptococcus suis isolates.
    Martel A; Baele M; Devriese LA; Goossens H; Wisselink HJ; Decostere A; Haesebrouck F
    Vet Microbiol; 2001 Nov; 83(3):287-97. PubMed ID: 11574176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.
    Montanari MP; Mingoia M; Giovanetti E; Varaldo PE
    J Clin Microbiol; 2001 Apr; 39(4):1311-5. PubMed ID: 11283047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mechanism of macrolide resistance in Streptococcus pneumoniae.
    Shortridge VD; Flamm RK; Ramer N; Beyer J; Tanaka SK
    Diagn Microbiol Infect Dis; 1996 Oct; 26(2):73-8. PubMed ID: 8985659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.
    Reig M; Galan J; Baquero F; Perez-Diaz JC
    Antimicrob Agents Chemother; 2001 Feb; 45(2):630-2. PubMed ID: 11158770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
    Morosini MI; Cantón R; Loza E; Negri MC; Galán JC; Almaraz F; Baquero F
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2427-31. PubMed ID: 11502509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
    Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ
    Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloned
    Oryaşın E; Bıyık HH; Tristram S; Bozdoğan B
    Microb Drug Resist; 2020 Jul; 26(7):747-751. PubMed ID: 31971866
    [No Abstract]   [Full Text] [Related]  

  • 30. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1998 Apr; 42(4):945-6. PubMed ID: 9559816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
    Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
    J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.
    Reinert RR; Franken C; van der Linden M; Lütticken R; Cil M; Al-Lahham A
    Int J Antimicrob Agents; 2004 Jul; 24(1):43-7. PubMed ID: 15225860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.
    Alós JI; Aracil B; Oteo J; Gómez-Garcés JL;
    J Antimicrob Chemother; 2003 Feb; 51(2):333-7. PubMed ID: 12562699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.
    Tait-Kamradt A; Clancy J; Cronan M; Dib-Hajj F; Wondrack L; Yuan W; Sutcliffe J
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2251-5. PubMed ID: 9333056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.
    Seppälä H; Skurnik M; Soini H; Roberts MC; Huovinen P
    Antimicrob Agents Chemother; 1998 Feb; 42(2):257-62. PubMed ID: 9527769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes.
    Giovanetti E; Brenciani A; Burioni R; Varaldo PE
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3750-5. PubMed ID: 12435672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
    Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
    Muhtarova AA; Gergova RT; Mitov IG
    J Glob Antimicrob Resist; 2017 Sep; 10():238-242. PubMed ID: 28735056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.
    Green M; Martin JM; Barbadora KA; Beall B; Wald ER
    Antimicrob Agents Chemother; 2004 Feb; 48(2):473-6. PubMed ID: 14742197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.